CAROLYN ARORASH: Open Payments
NPI 1386093995 · PASADENA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 7 payments from 6 companies in 2025. Trend: 2023 $996 · 2024 $96 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $140 |
| Corcept Therapeutics | 2 | $137 |
| Axsome Therapeutics, Inc. | 1 | $98 |
| Gilead Sciences, Inc. | 1 | $94 |
| JAZZ PHARMACEUTICALS INC. | 1 | $78 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $67 |
Products named: REZDIFFRA, Korlym, Auvelity, Epclusa, XYWAV, REXULTI.
Industry payments across TX — which companies pay providers there.
